Immuneering Corporation (NASDAQ:IMRX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andrew Gengos Other companies: Turn Therapeutics Inc. (Director · Since at least Oct 7, 2025); Terns Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Feb 24, 2025); LeonaBio, Inc. (CFO and Chief Business Officer · May 18, 2023 – Sep 3, 2024 · Past); Cyteir Therapeutics Inc (Chief Business Officer · Jun 17, 2021 – Feb 22, 2022 · Past); Synlogic Inc (Chief Operating Officer · Oct 9, 2017 – Mar 14, 2018 · Past) | Chief Financial Officer and Treasurer · Since at least Jul 16, 2026 |
| Laurie Keating Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Jul 6, 2026); PepGen Inc. (Director · Since at least May 5, 2022); Imago Biosciences Inc (Director · Nov 17, 2021 – Jan 11, 2023 · Past); Alnylam Pharmaceuticals, Inc. (EVP, Chief Legal Officer · Jan 11, 2021 – Aug 5, 2021 · Past) | Director · Since at least Jul 29, 2021 |
| Ann E Berman Other companies: Loews Corporation (Director · Since at least Mar 1, 2021); Cantel Medical Corp (Director · Apr 5, 2021 – Jun 2, 2021 · Past); Eaton Vance Corp (Director · Nov 1, 2020 – Feb 12, 2021 · Past) | Director · Since at least Jul 29, 2021 |
| Diana Hausman Other companies: Zentalis Pharmaceuticals, Inc. (Chief Medical Officer · May 8, 2023 – May 9, 2024 · Past); Zymeworks Inc. (Chief Medical Officer · Jan 1, 2019 – Mar 10, 2021 · Past); Cascadian Therapeutics Inc (Chief Medical Officer · Mar 5, 2012 – Sep 24, 2015 · Past) | Board Member · Since at least Jan 14, 2022 |
| Biren Amin Other companies: Social Capital Suvretta Holdings Corp IV (Director · Jun 29, 2022 – Jun 29, 2022 · Past) | CFO, TREASURER · Jul 29, 2021 – May 12, 2022 · Past |
| Igor Matushansky Other companies: Hookipa Pharma Inc (Chief Medical Officer · Apr 17, 2019 – Jun 30, 2022 · Past) | Chief Medical Officer · Since at least Mar 17, 2025 |
| Michael Bookman Other companies: Korro Bio, Inc. (General Counsel and Secretary · Jan 19, 2021 – Apr 20, 2021 · Past) | Chief Legal Officer, Secretary · Since at least Jul 29, 2021 |
| Thomas J Schall Other companies: ChemoCentryx Inc. (President and CEO, Director · Feb 8, 2012 – Oct 20, 2022 · Past) | Director · Since at least Mar 11, 2024 |
| Amy Axel | Director, Scientific Operations · Oct 2, 2026 – Nov 10, 2026 · Past |
| Anna Travesa | Executive Director, Discovery · Since at least Nov 4, 2026 |
| Benjamin J Zeskind | PRESIDENT AND CEO, Director · Since at least Jul 29, 2021 |
| Ben Zeskind | Co-Founder, President, Chief Executive Officer, Director · Since at least Jun 24, 2026 |
| Bob Carpenter | Co-founder, Chair Emeritus · Since at least Nov 10, 2026 |
| Brett Hall | Chief Scientific Officer · Since at least Jun 20, 2025 |
| David Caouette | Vice President, Corporate Communications · Since at least Oct 29, 2026 |
| Dominic Capasso | Associate General Counsel · Since at least Nov 10, 2026 |
| Doris Perez Diaz | Clinical Trial Manager · Since at least Nov 10, 2026 |
| Grant Bogle | Board Member · Since Nov 9, 2026 |
| Harold Eugene Brakewood | Chief Business Officer · Since at least Mar 27, 2023 |
| Jason Funt | Vice President, Translational Genomics · Since at least May 21, 2026 |
| Kevin D. Fowler | Vice President, Translational Research · Since at least Nov 5, 2026 |
| Leah Neufeld | CHIEF PEOPLE OFFICER · Since at least Oct 17, 2022 |
| Loretta Sullivan | Vice President, Medical Affairs and Scientific Development · Since at least Nov 10, 2026 |
| Mallory Morales | SVP Finance, CAO · Since at least Aug 11, 2022 |
| Marty Hughes | Executive Director, CMC · Since at least Nov 10, 2026 |
| Nair Praveen | Vice President, Head of Translational Pharmacology · Since at least Nov 10, 2026 |
| Paula George | Senior Director, Accounting & Operations; Assistant Corporate Controller · Since at least Nov 10, 2026 |
| Peter Feinberg | Board Member · Since at least Jul 29, 2021 |
| Praveen Nair | Vice President, Head of Translational Pharmacology · Nov 4, 2026 – Nov 10, 2026 · Past |
| Robert J Carpenter | Director · Since at least Jun 13, 2025 |
| Scott Barrett | CHIEF MEDICAL OFFICER · Jul 29, 2021 – Feb 15, 2023 · Past |
| Scott Nguyen | Executive Director, IT · Since at least Nov 10, 2026 |
| Stephen Sebastian | Executive Director, Corporate Controller · Since at least Nov 10, 2026 |
| Tom Schall | Board Chair · Since at least Nov 10, 2026 |
| Tyler Mead | Senior Manager, Financial Reporting and Internal Controls · Since at least Nov 10, 2026 |
| Vinny Hayreh | Vice President, Clinical Development · Since at least May 21, 2026 |
| Will Drew | Director, High Performance Computing · Nov 4, 2026 – Nov 10, 2026 · Past |
| Zhang Jenny | Executive Director, Genomic Data Science · Since at least Nov 10, 2026 |